Find clinical trials for AstraZeneca. Search for AstraZeneca clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 139
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: West Long Branch NJ, Silver Spring MD, Miami FL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT07430306
Phase 3, Recruiting
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Fairfax VA, Atlanta GA, Santa Monica CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07098338
Phase 2, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Halifax, Moncton, South Portland ME, Boston MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase 3, Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Halifax, Boston MA, Hamden CT, Quebec, Sherbrooke,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase 2, Recruiting
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07446855
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
for
Sepsis, Acute Kidney Injury
Location: Boston MA, Levis, Quebec, The Bronx NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07215702
Phase 2, Recruiting
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Location: New York NY, Chapel Hill NC, Ann Arbor MI
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07295847
Phase 1, Phase 2, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Moncton, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, Hartford CT, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase 3, Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
for
Multiple Sclerosis
Location: New York NY, Washington D.C. DC, Milwaukee WI,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 60
Code: NCT07224373
Phase 1, Recruiting
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma
Location: New York NY, Jacksonville FL, Franklin TN, Rochester MN
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07123454
Phase 1, Phase 2, Recruiting
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
for
Healthy Participants
Location: Baltimore MD, Glendale CA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT07290283
Phase 1, Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase 3, Recruiting
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Franklin TN, Chicago IL, Iowa City IA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07109219
Phase 1, Phase 2, Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
for
Advanced Solid Tumors
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07161414
Phase 1, Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Montreal, Margate FL, Miami FL, Springdale AR
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT07711002
Phase 3, Recruiting
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease